China Universal Asset Management Company’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $89.3K | Buy |
11,853
+116
| +1% | +$873 | 0.01% | 375 |
|
|
2025
Q1 | $88.8K | Sell |
11,737
-609
| -5% | -$4.61K | 0.01% | 365 |
|
|
2024
Q4 | $150K | Buy |
12,346
+1,195
| +11% | +$14.6K | 0.01% | 350 |
|
|
2024
Q3 | $187K | Buy |
11,151
+4,380
| +65% | +$73.3K | 0.02% | 309 |
|
|
2024
Q2 | $118K | Sell |
6,771
-2,225
| -25% | -$38.8K | 0.02% | 292 |
|
|
2024
Q1 | $153K | Buy |
8,996
+4,042
| +82% | +$68.9K | 0.02% | 324 |
|
|
2023
Q4 | $50.5K | Buy |
4,954
+3,859
| +352% | +$39.3K | 0.01% | 370 |
|
|
2023
Q3 | $9.91K | Buy |
1,095
+579
| +112% | +$5.24K | ﹤0.01% | 346 |
|
|
2023
Q2 | $5.55K | Sell |
516
-17
| -3% | -$183 | ﹤0.01% | 360 |
|
|
2023
Q1 | $5.45K | Buy |
533
+68
| +15% | +$696 | ﹤0.01% | 358 |
|
|
2022
Q4 | $4.91K | Buy |
465
+38
| +9% | +$401 | ﹤0.01% | 299 |
|
|
2022
Q3 | $5K | Buy |
+427
| New | +$5K | ﹤0.01% | 268 |
|